Development of stable freeze dried kits of 99mTc-ciprofloxacin for infection imaging

Journal of the Chemical Society of Pakistan

Volumn 37, Issue 4, 2015, Pages 643-648

  Shahzad, Shabnam ^a   Qadir, Muhammad Abdul ^a   Ahmed, Mahmood ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Antibiotic; Bacterial strains; Radio labelling; Scintigraphy

Indexed keywords

EID: 84953247848     PISSN: 02535106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. V. N. Cardoso, P. J. Plaza, M. Roca, F. Armero and J. Martín-Comin, Assessment of Inflammatory Bowel Disease by Using Two Different (99m)Tc Leucocyte Labelling Methods, Nucl. Med. Commun., 23, 715 (2002).
2. C. J. Palestro, The Current Role of Gallium Imaging in Infection, Semin. Nucl. Med., 24, 128 (1994).
3. M. Zasloff, Antimicrobial Peptides of Multicellular Organisms, Nature., 415, 389 (2002).
4. 99mTc] HMPAOLeukocytes for Imaging Infection, Semin. Nucl. Med., 24, 110 (1994).
5. A. B. Segura, A. Muñoz, Y. R. Brulles, H. J. A. Hernandez, M. C. Díaz, L. M. T. Bajen and C. J. Martín, What is the Role of Bone Scintigraphy in the Diagnosis of Infected Joint Prostheses, Nucl. Med. Commun., 25, 527 (2004).
6. M. Gandomkar, R. Najafi, M. Mazidi, M. Goudarzi and S. H. Mirfallah, New Peptide Based Freeze-Dried Kit [99mTc-HYNIC]-UBI 29-41 as a Human Specific Infection Imaging Agent, Iran J. Nucl. Med., 16, 25 (2008).
7. M. Gandomkar, R. Najafi, M. Shafiei, M. Mazidi, M. Goudarzi, S. H. Mirfallah, F. Ebrahimi, H. R. Heydarpor and N. Abdie, Clinical Evaluation of Antimicrobial Peptide [(99m)Tc/Tricine/HYNIC(0)] ubiquicidin 29-41 as a Human-Specific Infection Imaging Agent, Nucl. Med. Biol., 36, 199 (2009).
8. M. Gandomkar, R. Najafi, M. Mazidi, S. H. Mirfallah and M. Goudarzi, Three Different Procedures in Labeling of Ubiquicidin with Technetium 99m: a Comparative Study, Iran J. Radiat. Res., 7, 97 (2009).
9. M. M. Welling, P. H. Nibbering, A. A. Paulusma, P. S. Hiemstra, E. K. Pauwels and W. Calame, Imaging of Bacterial Infections with 99mTc-Labeled Human Neutrophil Peptide-1, J. Nucl. Med., 40, 2073 (1999).
10. B. Fournier, X. Zhao, T. Lu, K. Drlica and D. C. Hooper, Selective Targeting of Topoisomerase IV and DNA Gyrase in Staphylococcus aureus: Different Patterns of Quinolone-Induced Inhibition of DNA Synthesis, Antimicrob. Agents Chemother., 44, 2160 (2000).
11. K. K. Solanki, J. Bomanji, Q. H. Siraj, M. Small and K. E. Britton, Tc-99m Infecton: A New Class of Radiopharmaceutical for Imaging Infection, J. Nucl. Med., 34, 119 (1993).
12. N. Bhardwaj, A. Bhatnagar and A. K. Singh, Development and Evaluation of a Single Vial Cold Kit for Infection Imaging: Tc-99m Ciprofloxacin, World J. Nucl. Med., 4, 244 (2005).
13. S. Jurisson, D. Berning and W. M. D. Jia, Coordination Compounds in Nuclear Medicine, Chem. Rev., 93, 1137 (1993).
14. USP-36, Antibiotics, Microbial Assays, 2163 (2013).
15. K. E. Britton, S. Vinjamuri, A. V. Hall, K. Solanki, Q. H. Siraj, J. Bomanji and S. Das, Clinical Evaluation of Technetium-99m Infecton for the Localisation of Bacterial Infection, Eur. J. Nucl. Med., 24, 553 (1997).
16. L. Sarda, A. C. Crémieux, Y. Lebellec, A. Meulemans, R. Lebtahi, G. Hayem, R. Génin, N. Delahaye, D. Huten and G.D. Le, Inability of 99mTc-ciprofloxacin Scintigraphy to Discriminate Between Septic and Sterile Osteoarticular Diseases, J. Nucl. Med., 44, 920 (2003).